CompletedNCT02477670
What is this study about?This study evaluated the safety and effectiveness of AVP-786 for people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including CerritosSchizophreniaMedication studyAges 18–60
- Countries
- United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
CompletedNCT01668797
What is this study about?Researchers compared Brexpiprazole and placebo to find out how the approaches affected psychotic symptoms in adults with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including AnaheimSchizophreniaMedication studyAges 18–65
- Countries
- United States, Colombia, Malaysia, + 4 others
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
CompletedNCT00922272
Official study titleA Phase 2, Multicenter Study With Open-label & Randomized Double-blind Placebo-controlled Withdrawal Phases to Evaluate the Efficacy, Safety, & Tolerability of SPD489 in Adults With Schizophrenia & Predominant Negative Symptoms Who Are Clinically Stable & Taking Stable Doses of Atypical Antipsychotic Medication
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockSchizophreniaMedication studyAges 18–55
- Countries
- United States
- Sponsor
- Shire
CompletedNCT01516424
What is this study about?Researchers compared Blonanserin and Risperidone to find out how the approaches affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including BeijingSchizophreniaMedication studyAges 18–64
- Countries
- China
- Sponsor
- Marubeni Pharmaceuticals (Suzhou) Co., Ltd.
CompletedNCT00001921
Official study titleIntegrating EEG/MEG and fMRI: Activity Correlation Between Frontal and Temporal Lobe Structures in Schizophrenic Patients, Their Siblings and Unrelated Normal Volunteers
This study has finished and is no longer accepting participants.
In BethesdaSchizophreniaObservational studyAges 18–55
- Countries
- United States
- Sponsor
- National Institute of Mental Health (NIMH) (Government agency)